Catalent Balance Sheet Health

Financial Health criteria checks 2/6

Catalent has a total shareholder equity of $3.7B and total debt of $4.6B, which brings its debt-to-equity ratio to 125%. Its total assets and total liabilities are $10.0B and $6.3B respectively.

Key information

125.0%

Debt to equity ratio

US$4.61b

Debt

Interest coverage ration/a
CashUS$229.00m
EquityUS$3.69b
Total liabilitiesUS$6.30b
Total assetsUS$9.99b

Recent financial health updates

Recent updates

Catalent - Novo Holdings Merger: Attractive Spread

Feb 07

Catalent: Debt Remains An Overhang

Dec 13

Catalent Remains Overvalued

Oct 04

Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Aug 14
Calculating The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Catalent: Myriad Issues To Fix

Jul 31

Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet

May 05
Catalent (NYSE:CTLT) Has A Somewhat Strained Balance Sheet

A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Mar 27
A Look At The Intrinsic Value Of Catalent, Inc. (NYSE:CTLT)

Why did Catalent stock soar today? Potential takeover by Danaher

Feb 06

We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt

Feb 01
We Think Catalent (NYSE:CTLT) Is Taking Some Risk With Its Debt

Catalent to make Sarepta Therapeutics' muscle wasting gene therapy under supply deal

Jan 05

An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued

Dec 27
An Intrinsic Calculation For Catalent, Inc. (NYSE:CTLT) Suggests It's 27% Undervalued

Humanigen to pay Catalent Pharma $12M to settle supply agreement dispute

Dec 22

Catalent falls after new short call from Glasshouse Research

Dec 08

Catalent Q1 2023 Earnings Preview

Oct 31

These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively

Oct 26
These 4 Measures Indicate That Catalent (NYSE:CTLT) Is Using Debt Extensively

Catalent: Charting A Post-Covid Future

Oct 19

Calculating The Fair Value Of Catalent, Inc. (NYSE:CTLT)

Sep 16
Calculating The Fair Value Of Catalent, Inc. (NYSE:CTLT)

Catalent Non-GAAP EPS of $1.19 beats by $0.04, revenue of $1.31B misses by $20M

Aug 29

Financial Position Analysis

Short Term Liabilities: CTLT's short term assets ($2.6B) exceed its short term liabilities ($1.0B).

Long Term Liabilities: CTLT's short term assets ($2.6B) do not cover its long term liabilities ($5.3B).


Debt to Equity History and Analysis

Debt Level: CTLT's net debt to equity ratio (118.7%) is considered high.

Reducing Debt: CTLT's debt to equity ratio has reduced from 137% to 125% over the past 5 years.

Debt Coverage: CTLT's debt is not well covered by operating cash flow (3.8%).

Interest Coverage: Insufficient data to determine if CTLT's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.